LogicBio Therapeutics (LOGC) Misses Q4 EPS by 8c

March 12, 2025 4:36 PM

LogicBio Therapeutics (NASDAQ: LOGC) reported Q4 EPS of ($0.08).

For earnings history and earnings-related data on LogicBio Therapeutics (LOGC) click here.